Kevin Weber

Medicine · The Ohio State University

Mid career · publishing since 2014Rising activity

Migraine and Headache Studies Thyroid Disorders and Treatments Traumatic Brain Injury Research Memory and Neural Mechanisms Traumatic Brain Injury and Neurovascular Disturbances

Publications

Citations

191

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 2014

Research summary

AI-generated

Kevin Weber's work focuses on headache disorders, particularly migraine and its treatments, including botulinum toxin therapy and calcitonin gene-related peptide (CGRP)-targeted monoclonal antibody drugs. His publications also touch on related neurological topics such as trigeminal neuralgia, stress hormone responses, and drug interactions relevant to migraine patients with other medical conditions.

Migraine treatment and preventionCGRP-targeted therapiesBotulinum toxin (OnabotulinumtoxinA) for chronic migraineNeurological drug interactions and tolerabilityStress hormone and neuroendocrine responses

Publication output has been modest but has increased somewhat in recent years, rising from sporadic single papers earlier in the decade to multiple publications per year by 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence

Publications per year over the last 10 years — averaging 1.6/year recently

Recent publications

Comparing Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) and Targeted Approaches for OnabotulinumtoxinA in Chronic Migraine Treatment
Plastic & Reconstructive Surgery Global Open · 2026
Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors
Headache The Journal of Head and Face Pain · 2025
Tolerability of calcitonin gene-related peptide monoclonal antibodies and other monoclonal antibodies in adults with concurrent migraine and other medical conditions
Cephalalgia Reports · 2024
Triptans
Elsevier eBooks · 2024
Contributors
Elsevier eBooks · 2024
Differential effects of the translocator protein 18 kDa (TSPO) ligand etifoxine and the benzodiazepine alprazolam on startle response to predictable threat in a NPU-threat task after acute and short-term treatment
Psychopharmacology · 2022
List of contributors
Elsevier eBooks · 2021
Effect of hormones
Elsevier eBooks · 2021
Dissociation of endocrine responses to the Trier Social Stress Test in Virtual Reality (VR-TSST) by the benzodiazepine alprazolam and the translocator protein 18 kDa (TSPO) ligand etifoxine
Psychoneuroendocrinology · 2020
Neuromodulation and Devices in Trigeminal Neuralgia
Headache The Journal of Head and Face Pain · 2017
Palinopsia in a Patient with an Acute Occipital Lobe Stroke (P4.369)
Neurology · 2016

Publishes in

Elsevier eBooks×4
Headache The Journal of Head and Face Pain×2
Neurology×2
Psychoneuroendocrinology×1
Plastic & Reconstructive Surgery×1

Similar researchers

By research-topic overlap

Anna Schoenbrunner
Medicine · The Ohio State University
Caroline V. Brooks
Medicine · Indiana University
Alex Gordon
Medicine · Purdue University West Lafayette
Amanda Gusovsky
Medicine · The Ohio State University
Nihaal Reddy
Medicine · The Ohio State University

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile